Finding New Drugs for Sepsis Using Zebrafish
Author Information
Author(s): Widder Mark, Carbaugh Chance, van der Schalie William, Miller Ronald Jr., Brennan Linda, Moore Ashley, Campbell Robert, Akers Kevin, Ressner Roseanne, Martin Monica, Madejczyk Michael, Dancy Blair, Lee Patricia, Lanteri Charlotte
Primary Institution: Walter Reed Army Institute of Research
Hypothesis
Can an optimized zebrafish model effectively identify potential therapeutic drugs for sepsis?
Conclusion
The study identified three drugs that showed significant potential in rescuing zebrafish from sepsis-induced mortality and tail edema.
Supporting Evidence
- 29 drugs showed more than 60% rescue from sepsis symptoms.
- Three drugs produced 100% rescue and did not differ from controls in neurobehavioral tests.
- Further testing showed these drugs also rescued from mortality and tail edema in a more lethal model.
Takeaway
Researchers used baby fish called zebrafish to test many drugs and found three that can help treat a serious infection called sepsis.
Methodology
The study used a zebrafish model to screen 644 FDA-approved drugs for their ability to rescue from sepsis symptoms induced by lipopolysaccharide.
Limitations
The zebrafish model uses LPS instead of live bacteria, which may not fully replicate human sepsis.
Statistical Information
P-Value
p<0.001
Confidence Interval
95% confidence limits 61.8–73.8 µg/mL
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website